Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Freshpet (FRPT) appoints new CFO and SVP of Supply Chain, reaffirms 2025 outlook

Freshpet, Inc. (Nasdaq: FRPT) has announced the appointment of John O’Connor as Chief Financial Officer, effective February 9, 2026, and Ana Lopez as Senior Vice President of Supply Chain, effective February 2, 2026. This move comes as the company reaffirms its full-year 2025 outlook.

John O’Connor, who brings over 20 years of financial leadership experience, including extensive tenure in animal health and pet care, served most recently as Senior Vice President, Global Commercial Finance at Zoetis, the world’s largest animal health company. Ana Lopez, with more than 20 years of global supply chain leadership, most recently served as Senior Vice President, North America Foods Supply Chain at Unilever.

Freshpet has also reaffirmed its guidance for fiscal 2025, as provided in the Company’s press release on November 3, 2025. The Company expects to report financial results for its fourth quarter and full year 2025 on Monday, February 23, 2026.

Freshpet's mission is to elevate the way we feed our pets with fresh food that nourishes all. The company's foods are blends of fresh meats, vegetables, and fruits farmed locally and made at its Freshpet Kitchens. The foods are thoughtfully prepared using natural ingredients, cooking them in small batches at lower temperatures to preserve the natural goodness of the ingredients.

Freshpet foods and treats are kept refrigerated from the moment they are made until they arrive at Freshpet Fridges in various markets. The foods are available in select grocery, mass, digital, pet specialty, and club retailers across the United States, Canada, and Europe, as well as online in the U.S. As a result of these announcements, the company's shares have moved 1.56% on the market, and are now trading at a price of $64.25. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS